Back to Results
First PageMeta Content
Rheumatology / Pharmacology / Aging-associated diseases / Pain / Zucapsaicin / Osteoarthritis / Rheumatoid arthritis / WOMAC / Pain scale / Medicine / Health / Arthritis


Microsoft Word - Winston Pharmaceuticals July 7 Press Release - NDA.doc
Add to Reading List

Document Date: 2014-06-09 18:06:39

Open Document

File Size: 40,27 KB

Share Result on Facebook

Company

Winston Pharmaceuticals Winston / Winston Pharmaceuticals Inc. / Winston Laboratories Inc. / /

Continent

North America / /

Country

United States / Canada / /

Event

FDA Phase / /

IndustryTerm

treatment of signs and symptoms / chemical name / Treatment of Osteoarthritis / pharmaceutical / /

MedicalCondition

inflammatory bowel disease / arthritis / rheumatoid arthritis / episodic cluster headache / osteoarthritis / pain / chronic daily headache / mild-to-moderate joint pain / inflammation / Osteoarthritis Osteoarthritis / /

MedicalTreatment

adjunctive therapy / pain management / /

Organization

U.S. Food and Drug Administration / European Union / /

Person

Joel E. Bernstein / /

Position

President and CEO / /

Product

acetaminophen / ibuprofen / Tylenol / Motrin / Advil / CIVANEX / Canada / CIVANEX® (Civamide Cream) / CIVANEX® / /

ProvinceOrState

Illinois / /

Region

Western Ontario / /

SocialTag